Loading...
MTAA
FF
Market cap186mUSD
Oct 07, Last price  
6.94EUR
1D
-1.14%
1Q
-23.74%
Jan 2017
-25.12%
IPO
-26.25%
Name

Fine Foods & Pharmaceuticals NTM SpA

Chart & performance

D1W1MN
MTAA:FF chart
P/E
16.48
P/S
0.66
EPS
0.42
Div yield, %
2.02%
Shrs. gr., 5y
0.89%
Rev. gr., 5y
7.81%
Revenues
252m
+3.41%
00139,387,000159,658,000173,035,000194,424,000206,853,000251,812,000243,753,000252,058,868
Net income
10m
+23.80%
-196,837-187,0008,686,000-2,790,00013,364,000-1,427,000-9,501,000-3,522,0008,156,00010,097,286
CFO
32m
-30.73%
54,286-63,508-2,976,81319,205,43330,466,944-5,826,7153,688,37418,538,19545,850,89731,760,850
Dividend
Apr 20, 20260.16 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fine Foods & Pharmaceuticals N.T.M. S.p.A. functions as a contract development and manufacturing organization (CDMO), specializing in the creation of various oral solid forms for the pharmaceutical and nutraceutical sectors. Its pharmaceutical offerings include items such as powders, granules, capsules, standard and film-coated tablets, effervescent granules, and hard gelatine capsules. For the nutraceutical market, the company produces soluble, effervescent, and chewable tablets, fast-melting/sublingual tablets, film-coated tablets, and hard gelatine capsules, alongside soluble and effervescent powders and granules. These nutraceutical products are designed to support a wide range of health needs, encompassing areas like probiotics, multivitamins and minerals, immune system function, sleep and relaxation, gastrointestinal and circulatory health, osteoarticular and urinary systems, women's health, beauty, healthy aging, and mental wellbeing. In addition to its core CDMO services, the company also manufactures and sells a diverse array of cosmetic products, covering hair care, skin care, liquid personal hygiene items, oral hygiene products, deodorants, alcohol-based perfumery, bath and shower gels, shampoos and conditioners, shaping waxes, mouthwashes, creams, gels, and toothpastes. Furthermore, they supply medical surgical aids and devices, various antiseptics for intact skin, hand sanitizers, pre-injection solutions, hydroalcoholic surface cleaners, and iodine. Their product line also extends to orthodontic cleaning tablets, disinfectants, and decongestant nasal sprays. Established in 1984, the company is headquartered in Verdellino, Italy.

Related entities

Parent
EIGENFIN S.R.L.

Key people

Marco Eigenmann
Executive Chairman of the Board, Chief Executive Officer
Pietro Oriani
Chief Executive Officer, Executive Director · since 2024
Non-Executive Director
Giovanni Eigenmann
Non-Executive Director · since 2024
Adriano Pala Ciurlo
Non-Executive Director · since 2018
Elena Sacco
Non-Executive Director · since 2024
Chiara Fedrigoni
Non-Executive Independent Director · since 2021
Paolo Ferrario
Non-Executive Independent Director · since 2024
Ada Imperadore
Non-Executive Independent Director · since 2021
Non-Executive Lead Independent Director · since 2021
Deborah Venturini
Non-Executive Independent Director · since 2024
IPO date
Oct 19, 2016
Employees
Domiciled in
IT
Incorporated in
IT
Headquarters & legal address
VIA BERLINO, 39 (ZINGONIA)
VERDELLINO, BG 24040
IT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT